Código QR (código de barras bidimensional)

Safety and tolerability of first‐line durvalumab with tremelimumab and chemotherapy in esophageal squamous cell carcinoma

Abstract Background Advanced or metastatic esophageal squamous cell carcinoma (ESCC) is associated with poor prognosis; new first‐line systemic treatment options are needed. Combining immuno‐oncology therapies with standard chemotherapy may represent a promising approach for the treatment of solid t...

Fuld beskrivelse

Na minha lista:
Principais autores: Dae Ho Lee, Hye Ryun Kim, Bhumsuk Keam, Ken Kato, Yasutoshi Kuboki, Haiyan Gao, Alejandro Yovine, Scott H. Robbins, Myung‐Ju Ahn
Format: Artigo
Sprog:Inglês
Udgivet: Wiley 2023-08-01
Serier:Cancer Medicine
Fag:
chemotherapy
clinical trials
esophageal squamous cell
immunology
Online adgang:https://doi.org/10.1002/cam4.6260
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker